The Hematology Podcast

Sanofi
  • 0,0 (0)
  • FORME ET SANTÉ
  • TOUS LES MOIS
The Hematology Podcast

In The Hematology Podcast, we dig into the clinical, the theoretical, and the practical, as we discuss the past, present, and future of the hematological field. MAT-DK-2100201(1.0) March 2021

  1. 31 OCT.

    TMA or Thrombotic microangiopathy - from Symptoms to Treatment

    In this episode of The Hematology Podcast, we will delve into the complex world of thrombotic microangiopathy, or TMA. This condition encompasses a group of disorders characterized by small blood clots forming in the smallest blood vessels, leading to various complications. Diagnosing TMA can be particularly challenging due to its overlapping symptoms with other conditions and the need for specialized tests.In today’s episode, we have the honor of welcoming Professor Riitta Lassila to the stu...

    35 min

  2. 3 OCT.

    Decoding Multiple Myeloma genetic profile: The Power of Liquid Biopsy-Derived DNA

    In this episode, we dive into the fascinating world of liquid biopsy-derived DNA as a revolutionary tool for comprehensive mutation profiling in multiple myeloma. This innovative approach offers a non-invasive way to analyse genetic alterations, potentially transforming how we diagnose and monitor this complex hematological cancer. Join us as we explore the promises and challenges of using liquid biopsies to decode the genetic landscape of multiple myeloma and its implications for personalize...

    21 min

  3. 3 OCT.

    Transfusion Dependent Thalassemia - the Severe Spectrum

    In this episode, we focus on a severe form of Thalassemia known as Thalassemia major. In a previous episode, we discussed Thalassemia minor and intermedia with Professor Dr. Bart Biemond from Amsterdam UMC. Today, we’ll delve deeper into the challenges and treatments associated with Thalassemia major. Prof. Biemond is still with us to share his expertise. ASSET-24016319 (ver. 2.0) Oct 2024

    44 min

  4. 24 FÉVR.

    AML - from basics to future prospectives

    Acute myeloid leukemia (AML) is a hematopoietic stem cell-derived myeloid malignancy characterized by manifold genetic aberrations and poor overall survival. Standard treatment for newly diagnosed fit AML patients is intensive chemotherapy. Relapse is, however, a challenge in more than 40% of AML patients. AML is also a disease with a large degree of individual heterogeneity, which creates challenges both for diagnostics and for developing targeted treatment options. Our guest is Björn G...

    31 min

  5. 7 FÉVR.

    Smoldering Multiple Myeloma – to treat or not to treat?

    Smoldering multiple myeloma (SMM) is an intermediate condition that lies between Monoclonal gammopathy of undetermined significance (MGUS) and active multiple myeloma along the spectrum of clonal plasma cell proliferative disorders. Smoldering multiple myeloma may take years to become active multiple myeloma. In some cases, people who have this condition never develop active multiple myeloma. In this episode we have the pleasure of having the Norwegian haematologist Fredrik Schjesvold wi...

    26 min

  6. 2 FÉVR.

    Thalassemia - a blind spot

    Thalassemia is a hereditary blood disorder, in which the synthesis of hemoglobin chains is impaired. Consequently, people with thalassemia minor may have slight to severe anemia which usually does not cause any problems. Thalassemia major in contrast is a severe disorder with need of transfusion and complications with iron overload. In this episode we will mainly discuss thalassemia minor and intermedia. Our guest today Professor Bart Biemond is a hematologist at the Amsterdam UMC ...

    41 min

  7. 31/10/2023

    Causes, symptoms and diagnosing ASMD – A rare lysosomal storage disorder

    Today we will discuss a rare, inherited metabolic disorder known as ASMD, acid sphingomyelinase deficiency (or historically known as Niemann-Pick types A, A/B, and B). This genetic condition is very rare. It can be diagnosed, after suspicion, by different screening test. But symptoms may vary greatly, and has overlap with several other disorders, and the road to an accurate diagnosis can therefore be challenging. In today’s episode we have the pleasure of welcoming Professor David Cassim...

    38 min

  8. 26/10/2023

    MGRS- Monoclonal Gammopathy of Renal Significance

    Monoclonal gammopathy of renal significance (MGRS) is a hemato-nephrological term referring to a heterogeneous group of kidney disorders characterized by direct or indirect kidney injury caused by a monoclonal immunoglobulin (MIg) produced by a B cell or plasma cell clone that does not meet current hematologic criteria for therapy. MGRS-associated kidney diseases are diverse and can result in the development of end stage kidney disease (ESKD). In this episode we have the pleasure of having th...

    26 min
Tout afficher (21)

À propos

In The Hematology Podcast, we dig into the clinical, the theoretical, and the practical, as we discuss the past, present, and future of the hematological field. MAT-DK-2100201(1.0) March 2021

Informations

  • Création
    Sanofi
  • Années d’activité
    2021 - 2024
  • Épisodes
    21
  • Classification
    Tous publics
  • Copyright
    © 2024 Sanofi
  • Site web de l’émission
    The Hematology Podcast

Vous aimeriez peut‑être aussi

Pour écouter des épisodes au contenu explicite, connectez‑vous.

Recevez les dernières actualités sur cette émission

Connectez‑vous ou inscrivez‑vous pour suivre des émissions, enregistrer des épisodes et recevoir les dernières actualités.
Choisissez un pays ou une région

Afrique, Moyen‑Orient et Inde

Asie‑Pacifique

Europe

Amérique latine et Caraïbes

États‑Unis et Canada